Hong Kong Marine and Shipping Stock News

AGTech Holdings (SEHK:8279) has posted its FY 2026 first half numbers with revenue of HK$369.4 million and a basic EPS loss of HK$0.001214, while trailing twelve month figures show revenue of HK$760.5 million and a basic EPS loss of HK$0.00346 as the company remains unprofitable. Over the last three reported half year periods, revenue has moved from HK$271.4 million in 1H FY 2025 to HK$343.6 million in 2H FY 2025 and then to HK$369.4 million in 1H FY 2026. Net income has swung from a HK$1.97...

Shanghai Iluvatar CoreX Semiconductor (SEHK:9903) is drawing investor attention after recent trading, with the stock last closing at HK$530. Recent performance has been mixed, including a 2.8% single day decline and gains over the month. See our latest analysis for Shanghai Iluvatar CoreX Semiconductor. Against that backdrop, Shanghai Iluvatar CoreX Semiconductor has seen a strong build up in momentum, with a 7.72% 30 day share price return and a 64.09% 90 day share price return, contributing...

Global markets have experienced a volatile week, with small-cap equities leading the advance amid cautious optimism around geopolitical developments and fluctuating energy prices. In such an environment, penny stocks—often representing smaller or newer companies—remain an intriguing area for investors seeking growth opportunities beyond well-known names. Although the term 'penny stock' might seem outdated, these stocks can still offer significant potential when backed by strong financials and...

The recent 10% drop in Du Du Holdings Limited's ( HKG:8250 ) stock could come as a blow to insiders who purchased...

As global markets navigate a complex landscape of geopolitical tensions and inflationary pressures, Asia's stock markets have shown mixed performance, with indices reflecting both resilience in certain sectors and challenges in others. Amid these fluctuations, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on market inefficiencies. A good stock in this context often exhibits strong fundamentals that are not fully reflected in its current...

Amid heightened inflation pressures and geopolitical tensions, Asian markets have been navigating a complex landscape. As investors search for opportunities, penny stocks remain an intriguing area of focus due to their potential for value and growth. Although the term "penny stocks" might seem outdated, these smaller or less-established companies can offer significant opportunities when backed by strong financials.

CSPC Pharmaceutical Group recently reported two advances: U.S. FDA clearance to begin clinical trials of its once‑monthly semaglutide injection for weight management, and positive Phase III breast cancer data for its HER2 bispecific antibody regimen presented as a late‑breaking oral at the 2026 ASCO meeting. Together, these developments spotlight CSPC’s efforts to build a differentiated pipeline in obesity and oncology, targeting large global treatment areas with clinically sophisticated...

Shanghai Electric Group Co., Ltd. was recently added to the SSE 180 Index and, earlier this month, shareholders approved amendments to the company’s Articles of Association along with a final cash dividend of RMB 0.1425 per 10 shares for 2025, with H-share holders of record on June 22, 2026 set to be paid on July 31, 2026. This combination of index inclusion and confirmed shareholder returns may influence how both passive and active investors assess Shanghai Electric Group’s role in China’s...

Sun Art Retail Group (SEHK:6808) is in focus after its RT-Mart unit launched a Fresh Snack store-in-store pilot with Three Squirrels at nine East China locations to address demand for healthier snacks. See our latest analysis for Sun Art Retail Group. The RT-Mart and Three Squirrels rollout comes at a time when Sun Art Retail Group’s share price has fallen 36.21% year to date and its 1 year total shareholder return has declined 50.27%, suggesting sentiment around its turnaround efforts...

Recent deal activity at Everest Medicines (SEHK:1952), including the LNZ100 ophthalmology license in Greater China and the Sumecigrel cardiovascular collaboration, has put the stock back in focus for investors evaluating its business development approach. See our latest analysis for Everest Medicines. These licensing deals have arrived during a weak patch for the stock, with the share price down 26.91% year to date and the 1-year total shareholder return falling 45.09%. However, the 3-year...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

As global markets navigate through heightened inflation pressures and geopolitical tensions, Asian equities present a complex landscape with both challenges and opportunities. In this environment, identifying undervalued stocks can be particularly appealing for investors seeking to capitalize on potential discounts; these stocks often exhibit strong fundamentals or growth prospects that are not yet fully reflected in their current prices.

Amid a backdrop of global economic shifts, Asian markets have been navigating a complex landscape influenced by geopolitical tensions and evolving trade dynamics. In this context, penny stocks—often associated with smaller or emerging companies—continue to capture investor interest due to their potential for growth despite being considered niche investments today. As we explore three noteworthy Asian penny stocks, we focus on those that combine solid financial health with the promise of...

Dah Sing Financial Holdings (SEHK:440) has announced several governance changes, including appointing KPMG as auditor after PwC’s retirement and adding experienced Norinchukin executive Kiyoshige Uesugi to the board, drawing attention to oversight and risk control. See our latest analysis for Dah Sing Financial Holdings. The HK$40.7 share price has had a mixed few months, with a 1-day share price return of 5.82% and a 30-day share price return that declined 4.10%. However, a 1-year total...

Amidst global economic fluctuations and geopolitical tensions, Asian markets have been navigating a complex landscape marked by mixed signals from trade data and inflationary pressures. As investors seek opportunities within this environment, identifying undervalued stocks becomes crucial, especially those trading below their intrinsic value, offering potential for growth despite prevailing uncertainties.

Dividend approval and audit reappointment set the stage for China Foods China Foods (SEHK:506) drew investor attention after its 9 June 2026 AGM, where shareholders approved a final ordinary dividend of RMB 0.154 per share and reappointed Baker Tilly Hong Kong Limited as auditor. See our latest analysis for China Foods. At a share price of HK$3.46, China Foods has seen its 1 year total shareholder return of 17.51% contrast with a weaker year to date share price return of a 19.53% decline,...

Cathay Pacific Airways has announced that Chief Financial Officer and Executive Director Rebecca Jane Sharpe will retire from the Swire group on 1 October 2026, to be succeeded by Gavin John March, currently finance director at Swire Bulk Holdings. The planned handover to March, who brings aviation, engineering and shipping finance experience from across the Swire group, reshapes the airline’s senior financial leadership profile. We’ll now examine how this planned CFO transition to Gavin...

Clinical trial approval for TUL321 puts United Laboratories in focus United Laboratories International Holdings (SEHK:3933) has received approval from China's National Medical Products Administration to begin clinical trials for TUL321, an autoimmune drug that already holds U.S. FDA Investigational New Drug clearance. See our latest analysis for United Laboratories International Holdings. Those clinical trial and buyback announcements come after a tough spell for the stock. The 1-year total...

Board changes put governance and oversight in focus China Literature (SEHK:772) used its 2 June annual general meeting to reshuffle its independent board lineup, introduce fresh expertise in law and accounting, and approve updated constitutional documents. For investors, these moves raise practical questions about how audit quality, risk oversight, and intellectual property decisions might be handled over the coming years, especially given the company’s role within Tencent’s broader content...

In May 2026, Longfor Group Holdings reported unaudited contracted sales of RMB3.32 billion for the month and RMB13.67 billion for the first five months, alongside RMB11.14 billion of aggregated revenue from property operation and services and the acquisition of a new 76,985 sqm land plot for RMB374 million. Morgan Stanley highlighted Longfor Group’s proactive de-stocking approach and improving mall rental performance as key elements in its ongoing balance sheet risk reduction efforts. We’ll...

Ascentage Pharma Group International (SEHK:6855) drew fresh market attention after presenting new ASCO 2026 data on olverembatinib in chronic myeloid leukemia and first clinical results for alrizomadlin in pediatric sarcomas. See our latest analysis for Ascentage Pharma Group International. The ASCO 2026 updates arrived as the stock posted a 3.93% 1 day share price gain to HK$34.9. That move sits against a year to date share price decline of 31.43% and a 1 year total shareholder return that...

XtalPi Holdings (SEHK:2228) has entered a new partnership with a major international biopharma company to develop oral small molecule drugs targeting a complex GPCR. The collaboration uses XtalPi's AI and quantum physics platforms, combined with automated labs, to work on challenging GPCR targets. The deal carries a potential value of more than US$400 million, reflecting meaningful commercial scope for XtalPi's technology. XtalPi Holdings trades at HK$7.04, with the share price down 6.0%...

Majestic Dragon AeroTech Holdings (SEHK:918) has released fresh numbers for FY 2026, with first half revenue of HK$75.8 million and basic EPS of HK$0.005443 setting the tone for how you might read the rest of the year. The company reported revenue of HK$18.1 million in the first half of FY 2025 and HK$100.6 million in the second half of FY 2025, with EPS shifting from a loss of HK$0.014725 to a loss of HK$0.00439. The latest positive EPS print therefore sits against a mixed recent history...

Shareholders of Chow Tai Fook Jewellery Group Limited ( HKG:1929 ) will be pleased this week, given that the stock...